Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
SMMT
#666
Summit Therapeutics Inc. Common Stock
20.850
0
USD
+4.09%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+4.09%
Aylık Değişim
+29.66%
6 aylık değişim
+4.98%
Yıllık Değişim
+4.98%
Önceki Kapanış
20.030
0
Open
20.850
0
Bid
Ask
Low
20.850
0
High
20.850
0
Hacim
80
Piyasalar
ABD Borsası
Sağlık Hizmetleri
SMMT
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
82.92 M
98.12 M
697.69 M
701.7 M
737.68 M
775.37 M
—
Valuation ratios
Enterprise value
323.29 M
192.16 M
3.14 B
1.89 B
13.07 B
13.34 B
58.1 B
Price to earnings ratio
-6.18
-2.8
-12.2
-2.67
-57.56
-12.15
-106.61
Price to sales ratio
379.96
137.16
1 371.18
—
—
-21.44 K
-242.26 K
Price to cash flow ratio
-6.79
-3.42
-23.25
-21.31
-90.23
-40.5
-253.14
Price to book ratio
4.11
2.98
7.63
21.06
32.98
19.85
53.73
Enterprise value to EBITDA ratio
-4.56
-1.82
-36.83
-2.91
-57.08
-12.1
-103.67
Profitability ratios
Return on assets %
-0.51
-0.78
-0.12
-3.03
-0.51
-1.44
-3.09
Return on equity %
-0.66
-1.06
-0.62
-7.91
-0.57
-1.64
-3.9
Return on invested capital %
-824.67
-1 235.4
-172.33
-1 492.71
-3 507.86
-10.84 K
—
Gross margin %
100
100
100
—
—
100
400
Operating margin %
-6 185.23
-4 764.29
-10.23 K
—
—
179.51 K
458.89 K
EBITDA margin %
-8 250.35
-5 848.92
-12.09 K
—
—
180.64 K
458.64 K
Net margin %
-6 127.56
-4 897.84
-11.17 K
—
—
176.98 K
456.03 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
4.41
3.8
16.93
9.3
10.15
9.87
29.42
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.01
0.02
0
0
0
-0
-0
Solvency ratios
Debt to assets ratio
—
—
—
0.52
0.02
—
—
Debt to equity ratio
—
—
—
1.37
0.02
—
—
Long term debt to total assets ratio
—
—
—
0.49
0
—
—
Long term debt to total equity ratio
—
—
—
1.29
0
—
—
Per share metrics
Operating cash flow per share
-0.69
-0.79
-0.22
-0.12
-0.2
-0.43
-0.43
EBIT per share
-1.04
-1.16
-0.45
-0.99
-0.31
-1.46
-1.47
EBITDA per share
-1.02
-1.15
-0.44
-0.99
-0.32
-1.47
-1.48
Total debt per share
—
—
—
0.17
0.01
—
—
Cash per share
0.96
0.78
1.8
0.3
0.57
0.95
2.17
Net current asset value per share
1.26
1.05
3.4
0.31
0.59
0.96
2.21
Tangible book value per share
0.95
0.77
0.65
0.12
0.54
0.88
1.94
Working capital per share
0.97
0.78
3.2
0.27
0.53
0.87
1.9
Book value per share
1.14
0.9
0.66
0.13
0.54
0.88
1.96
Haberler
Stifel, Summit Therapeutics hissesi için al önerisiyle başladı
Summit Therapeutics hisseleri için Overweight tavsiyesi korundu
Why Is Ironwood (IRWD) Down 13.9% Since Last Earnings Report?
Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)
Jefferies, Summit Therapeutics hissesini düşürdü
Jefferies downgrades Summit Therapeutics stock rating on trial risks
Micron and Facebook among market cap stock movers on Friday
Summit Therapeutics Konferansta İvonescimab Hakkında Bilgi Verdi
Summit Therapeutics at The Citizens Life Sciences Conference: Strategic Insights on Ivonescimab
Summit Therapeutics Inc. (SMMT) Presents at The Citizens Life Sciences Conference 2026 Transcript
Summit Therapeutics TD Cowen Konferansı: Ivonesimab Odaklı Strateji
Summit Therapeutics at TD Cowen Conference: Strategic Focus on Ivonesimab